Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000517600 | SCV000614530 | benign | not specified | 2019-10-18 | criteria provided, single submitter | clinical testing | |
Molecular Genetics of Inherited Kidney Disorders Laboratory, |
RCV001254275 | SCV001430240 | uncertain significance | Autosomal dominant polycystic kidney disease | 2019-01-01 | criteria provided, single submitter | research | |
Gene |
RCV001576333 | SCV001803496 | likely benign | not provided | 2020-02-20 | criteria provided, single submitter | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV005398740 | SCV006055055 | likely benign | Polycystic kidney disease, adult type | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003925547 | SCV004740244 | uncertain significance | PKD1-related disorder | 2023-11-01 | no assertion criteria provided | clinical testing | The PKD1 c.74G>T variant is predicted to result in the amino acid substitution p.Gly25Val. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.050% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/16-2185617-C-A). Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |